An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
AIDS Malignancy Consortium
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Pfizer
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service